Albarado, Johnrey .

HRN: 18-59-29  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/30/2024
CEFTRIAXONE 1G (VIAL)
05/30/2024
06/05/2024
IV
1.5g
OD
PCAP-C
Waiting Final Action 
05/31/2024
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
05/31/2024
06/07/2024
IV
315mg
Q8
SEPSIS
Waiting Final Action 
06/04/2024
CEFTRIAXONE 1G (VIAL)
06/04/2024
06/06/2024
IV
1.5g
Q12hours
PCAP-C
Waiting Final Action 
06/05/2024
CEFTRIAXONE 1G (VIAL)
06/05/2024
06/26/2024
IV DRIP
1.5g
Q12H
Pcap C
Waiting Final Action 
06/05/2024
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
06/05/2024
06/11/2024
IVTT
500mg
Q8h
FOBT Positive
Waiting Final Action 
06/06/2024
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
06/06/2024
06/12/2024
IV
4.5g
Q8
PCAP Severe
Waiting Final Action 
06/06/2024
CEFTRIAXONE 1G (VIAL)
06/06/2024
06/13/2024
IV
1.5g
Q12h
T/C Meningitis
Waiting Final Action 
06/08/2024
MUPIROCIN 2%, 15G (TUBE)
06/08/2024
06/15/2024
TOPICAL
Ample Amount
BID
Bed Sores
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: